Psychoactive drugs and pilot performance: A comparison of nicotine, donepezil, and alcohol effects

Neuropsychopharmacology

Volumn 28, Issue 7, 2003, Pages 1366-1373

  Mumenthaler, Martin S ^a   Yesavage, Jerome A ^a,b   Taylor, Joy L ^a,b   O'Hara, Ruth ^a   Friedman, Leah ^a   Lee, Hana ^a   Kraemer, Helena C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Aerospace medicine; Cholinergic agents; Cognition; Ethanol; Psychomotor performance; Psychopharmacology

Indexed keywords

ALCOHOL; DONEPEZIL; NICOTINE; CENTRAL DEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; NICOTINIC AGENT; PIPERIDINE DERIVATIVE; PSYCHOTROPIC AGENT;

AIRPLANE PILOT; ALCOHOL INTOXICATION; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; MEMORY; NORMAL HUMAN; PRIORITY JOURNAL; SPACE; TASK PERFORMANCE; ADULT; AIRCRAFT; AREA UNDER THE CURVE; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; MOTOR PERFORMANCE; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SPACE FLIGHT; TIME;

ADULT; AIRCRAFT; AREA UNDER CURVE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOLINESTERASE INHIBITORS; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; MOTOR SKILLS; NICOTINE; NICOTINIC AGONISTS; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; PSYCHOTROPIC DRUGS; SPACE SIMULATION; TIME FACTORS;

EID: 0042924143     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300202     Document Type: Article

References (41)

1. Albuquerque EX, Santos MD, Alkondon M, Pereira EFR, Maelicke A (2001). Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Dis Assoc Disord 15(Suppl 1): S19-S25.
2. Arthur D, Levin ED (2002). Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. Psychopharmacology (Berl) 160: 140-145.
3. Bartus RT, Dean RLD, Beer B, Lippa AS (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414.
4. Bartus RT, Uehara Y (1979). Physostigmine and recent memory: effects in young and aged nonhuman primates. Science 206: 1087-1089.
5. Christie JE, Shering A, Ferguson J, Glen AI (1981). Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia. Br J Psychiatry 138: 46-50.
6. Cohen J (1977). Statistical Power Analysis for the Behavioral Sciences, rev edn Academic Press: New York.
7. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn, rev edn Lawrence Earlbaum Associates: Hillsdale, NJ.
8. Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS (1978). Physostigmine: improvement of long-term memory processes in normal humans. Science 201: 272-274.
9. Everitt BJ, Robbins TW (1997). Central cholinergic systems and cognition. Ann Rev Psychol 48: 649-684.
10. Francis PT, Palmer AM, Snape M, Wilcock GK (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. 66: 137-147.
11. Furey ML, Pietrini P, Haxby JV, Alexander GE, Lee HC, VanMeter J et al (1997). Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci USA 94: 6512-6516.
12. Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ (1997). Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I. Brain Res 771: 89-103.
13. Kazdin AE, Bass D (1989). Power to detect differences between alternative treatments in comparative psychotherapy outcome research. J Consult Clin Psychol 57: 138-147.
14. Kraemer HC (1992). Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance. Psychoneuroendocrinology 17: 527-536.
15. Kraemer HC, Thieman S (1987). How many Subjects? Sage Publications: Newbury Park.
16. Levin ED, Kaplan S, Boardman A (1997). Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. Behav Pharmacol 8: 236-242.
17. Levin ED, Simon BB (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138: 217-230.
18. Levin ED, Torry D (1996). Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berl) 123: 88-97.
19. Mentis MJ, Sunderland T, Lai J, Connolly C, Krasuski J, Levine B et al (2001). Muscarinic versus nicotinic modulation of a visual task. A pet study using drug probes. Neuropsychopharmacology 25: 555-564.
20. Min SK, Moon IW, Ko RW, Shin HS (2001). Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers. Psychopharmacology (Berl) 159: 83-88.
21. Muir JL (1997). Acetylcholine, aging, and Alzheimer's disease. Pharmacol, Biochem Behav 56: 687-696.
22. Mumenthaler MS, O'Hara R, Taylor JL, Friedman L, Yesavage JA (2001a). Influence of the menstrual cycle on flight simulator performance after alcohol ingestion. J Stud Alcohol 62: 422-433.
23. Mumenthaler MS, O'Hara R, Taylor JL, Yesavage JA (2001b). Relationship between variation in estradiol and progesterone levels across the menstrual cycle and human performance. Psychopharmacology 155: 198-203.
24. Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA (1998). Influence of nicotine on simulator flight performance in non-smokers. Psychopharmacology 140: 38-41.
25. Mundt JC, Ross LE (1993). Methodological issues for evaluation of alcohol and other drug effects: examples from flight-simulator performance. Behav Res Methods Inst Comput 253: 360-365.
26. Nathan PJ, Baker A, Carr E, Earle J, Jones M, Nieciecki M et al (2001). Cholinergic modulation of cognitive function in healthy subjects: acute effects of donepezil, a cholinesterase inhibitor. Hum Psychopharmacol 16: 481-483.
27. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000). Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Fundam Exp Clin Pharmacol 22: 89-95.
28. O'Neill J, Fitten LJ, Siembieda DW, Crawford KC, Halgren E, Fisher A et al (1999). Divided attention-enhancing effects of AF102B and THA in aging monkeys. Psychopharmacology 143: 123-130.
29. Rogers SL (1998). Perspectives in the management of Alzheimer's disease: clinical profile of donepezil. Dementia Geriatric Cogn Disord 9(Suppl 3): 29-42.
30. Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998). Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 158: 1021-1031.
31. Rogers SL, Friedhoff LT (1996). The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia 7: 293-303.
32. Rusted JM, Warburton DM (1989). Cognitive models and cholinergic drugs. Neuropsychobiology 21: 31-36.
33. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989). The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797-800.
34. Sherwood N, Kerr JS, Hindmarch I (1992). Psychomotor performance in smokers following single and repeated doses of nicotine gum. Psychopharmacology 108: 432-436.
35. Sitaram N, Weingartner H, Gillin JC (1978). Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Science 201: 274-276.
36. Taylor JL, O'Hara R, Mumenthaler MS, Yesavage JA (2000). Relationship of CogScreen-AE to flight simulator performance and pilot age. Aviat Space Environ Med 71: 373-380.
37. Taylor JL, Dolhert N, Friedman L, Mumenthaler MS, Yesavage JA (1996). Alcohol elimination and simulator performance of male and female aviators: a preliminary report. Aviat Space Environ Med 67: 407-413.
38. Taylor JL, Dolhert N, Morrow D, Friedman L, Yesavage JA (1994). Acute and 8-hour effects of alcohol (0.08% BAC) on younger and older pilots' simulator performance. Aviat Space Environ Med 65: 718-725.
39. Vidal C (1996). Nicotinic receptors in the brain. Molecular biology, function, and therapeutics. Mol Chem Neuropathol 28: 3-11.
40. Yesavage JA, Dolhert N, Taylor JL (1994). Flight simulator performance of younger and older aircraft pilots: effects of age and alcohol. J Am Geriatr Soc 42: 577-582.
41. Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J et al (2002). Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59: 123-125.